Eltrombopag Clonmel 50 mg film-coated tablets
Authorisation PA0126/377/002 · Clonmel Healthcare Ltd
- Licence holder
- Clonmel Healthcare Ltd (all products →)
- Active substance
- Eltrombopag olamine
- Clinical trials
- 12 clinical trials →
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC code
- B02BX05
- First authorised
- 21/02/2025
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Eltrombopag olamine: supply and approvals
29 authorised products on the HPRA list contain Eltrombopag olamine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 1 year (since 21 February 2025). The HPRA list marks it as marketed in Ireland.
Other medicines with Eltrombopag olamine in Ireland
25 other products on the HPRA list contain Eltrombopag olamine, from 8 licence holders; 3 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Eltrombopag Clonmel 25 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Eltrombopag Teva 25 mg Film-coated Tablets | TEVA GmbH | National authorisation (PA) | Marketed |
| Eltrombopag Teva 50 mg Film-coated Tablets | TEVA GmbH | National authorisation (PA) | Marketed |
| Eltrombopag Accord 12.5 mg film-coated tablets | Accord Healthcare S.L.U. | Centralised EU authorisation | Not stated |
| Eltrombopag Accord 25 mg film-coated tablets | Accord Healthcare S.L.U. | Centralised EU authorisation | Not stated |
| Eltrombopag Accord 50 mg film-coated tablets | Accord Healthcare S.L.U. | Centralised EU authorisation | Not stated |
| Eltrombopag Accord 75 mg film-coated tablets | Accord Healthcare S.L.U. | Centralised EU authorisation | Not stated |
| Eltrombopag Clonmel 75 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Eltrombopag MSN 25 mg film-coated tablets | MSN Labs Europe Limited | National authorisation (PA) | Not marketed |
| Eltrombopag MSN 50 mg film-coated tablets | MSN Labs Europe Limited | National authorisation (PA) | Not marketed |
| Eltrombopag Rowex 12.5 mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Not marketed |
| Eltrombopag Rowex 25 mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Not marketed |
The licence holder
Clonmel Healthcare Ltd holds 429 products on the HPRA list, with 174 different active substances; 325 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.